Absolute and Relative Contraindications of Amisulpride
The only absolute contraindication to amisulpride is known hypersensitivity to the drug itself 1.
Absolute Contraindications
- Known hypersensitivity to amisulpride - This is the sole FDA-labeled absolute contraindication 1
Relative Contraindications and High-Risk Situations Requiring Caution
While not explicitly labeled as absolute contraindications, the following conditions represent situations where amisulpride should be avoided or used with extreme caution due to significant safety concerns:
Cardiac Conditions
Congenital long QT syndrome - Amisulpride causes dose- and concentration-dependent QT prolongation 1. While research shows that at therapeutic doses (5-10 mg IV for PONV), the QTc prolongation is not clinically meaningful (maximum 8.0 milliseconds) 2, patients with congenital long QT syndrome should avoid this medication entirely.
Concurrent use with droperidol - This combination should be avoided due to additive QT prolongation effects 1.
Conditions Requiring ECG Monitoring
The following patients require ECG monitoring if amisulpride is used 1:
- Pre-existing arrhythmias or cardiac conduction disorders
- Electrolyte abnormalities (hypokalemia, hypomagnesemia)
- Congestive heart failure
- Concurrent use of other QT-prolonging medications (e.g., ondansetron)
- Other medical conditions known to prolong QT interval
Renal Impairment
While not explicitly contraindicated in the provided evidence, amisulpride is predominantly eliminated unchanged in the urine 3, suggesting dose adjustment or avoidance may be necessary in severe renal failure.
Important Clinical Considerations
Prolactin elevation - Amisulpride has a pronounced prolactin-elevating effect that is independent of dosage and duration 4. While this reverses rapidly after discontinuation, it should be considered in patients where hyperprolactinemia would be particularly problematic.
Extrapyramidal symptoms - Despite claims of low EPS risk, extrapyramidal side effects including akathisia, acute dystonia, and drug-induced parkinsonism can occur even at low doses 5. This is particularly relevant when considering amisulpride for negative symptoms at 50 mg twice daily 6.
Pediatric use - Limited safety data exists in children and adolescents, with observed side effects including increased appetite, weight gain, sedation, and mild extrapyramidal symptoms 7, 8. Use in this population should be approached cautiously.